The Impact of Exercise Methods on Human Body Functions and Metabolism (EXMET-BW&Y)

July 22, 2024 updated by: Jin Li, Zhoukou Normal University

Comparative Study on the Effects of Brisk Walking and Yoga on Glucose and Lipid Metabolism and Neurocognitive Function in Adults: A Randomized Controlled Trial

The objective of this study is to compare the effects of 8 months of yoga and walking exercise training on weight-related body fat and metabolic biomarkers in women. Participants will be randomly assigned to either a yoga group or a walking group. The yoga group will undergo 90-minute sessions, 3 times per week, while the walking group will engage in one-hour sessions, 6 times per week. Physical and metabolic markers will be measured at baseline and after 8 months of intervention.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This randomized controlled trial aims to investigate the differential impacts of yoga and walking exercise training on weight-related body fat and metabolic biomarkers in women over an 8-month period. The study will recruit women aged 18-65 years, who will be randomly assigned to either a yoga group or a walking group.

Yoga Group: Participants in the yoga group will attend 90-minute yoga sessions, 3 times per week.

Walking Group: Participants in the walking group will engage in one-hour fast-paced walking sessions, 6 times per week.

Outcome Measures: Physical and metabolic markers will be assessed at baseline and after 8 months of exercise intervention. The primary outcomes will include changes in body weight, BMI, visceral fat, and basal metabolism. Metabolic biomarkers such as serum leptin, glucose, total cholesterol (TC), apolipoprotein A (APOA), and apolipoprotein B (APOB) will also be measured.

Participants will be monitored for adherence to the exercise protocol and any adverse events throughout the study. Data will be collected during the intervention, and analyzed to determine the differential effects of yoga and walking on the measured outcomes.

The study aims to provide insights into the relative benefits of yoga and walking exercise regimens on women's health, particularly in terms of body composition and metabolic health, thereby informing future exercise recommendations and health interventions.

Study Type

Interventional

Enrollment (Estimated)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Henan
      • Zhoukou, Henan, China
        • Recruiting
        • Zhou Kou Normal University
        • Contact:
          • Jin Li

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Female participants aged 18-65 years; Willing and able to participate in an 8-month exercise program; Generally healthy with no contraindications to physical activity; Ability to provide informed consent

Exclusion Criteria:

Current participation in a structured exercise program; Known cardiovascular, respiratory, or metabolic disorders that contraindicate exercise; Pregnancy or planning to become pregnant during the study period; Use of medications affecting metabolism or physical activity levels; Any other condition that, in the opinion of the investigators, would make participation unsafe or not feasible

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Yoga Group
Participants in this group will undergo 90-minute yoga sessions, 3 times per week, for 8 months. The yoga intervention includes a combination of asanas (postures), pranayama (breathing exercises), and meditation designed to improve flexibility, strength, and mental well-being.
Participants in the yoga group will attend 90-minute yoga sessions, 3 times per week, for 8 months. The sessions will include a combination of asanas (postures), pranayama (breathing exercises), and meditation.
Experimental: Walking Group
Participants in this group will engage in one-hour fast-paced walking sessions, 6 times per week, for 8 months. The walking intervention is designed to improve cardiovascular fitness, endurance, and support weight loss.
Participants in the brisk walking group will engage in one-hour fast-paced walking sessions, 6 times per week, for 8 months. The walking regimen is designed to improve cardiovascular fitness, endurance, and support weight loss.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body Weight
Time Frame: Baseline, 8 months
Measurement of body weight changes in kilograms from baseline to 8 months.
Baseline, 8 months
Change in Body Mass Index (BMI)
Time Frame: Baseline, 8 months
Measurement of BMI changes calculated as weight in kilograms divided by height in meters squared from baseline to 8 months.
Baseline, 8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Serum Leptin Levels
Time Frame: Baseline, 8 months
Measurement of serum leptin levels in ng/mL from baseline to 8 months.
Baseline, 8 months
Change in Fasting Blood Glucose Levels
Time Frame: Baseline, 8 months
Measurement of fasting blood glucose levels in mg/dL from baseline to 8 months.
Baseline, 8 months
Change in Total Cholesterol (TC) Levels
Time Frame: Baseline, 8 months
Measurement of total cholesterol levels in mg/dL from baseline to 8 months.
Baseline, 8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: xiaomeng liu, Zhoukou Normal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 3, 2024

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

July 22, 2024

First Submitted That Met QC Criteria

July 22, 2024

First Posted (Actual)

July 26, 2024

Study Record Updates

Last Update Posted (Actual)

July 26, 2024

Last Update Submitted That Met QC Criteria

July 22, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The data will not be shared due to concerns about participant privacy and the sensitivity of the health data collected.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome

Clinical Trials on Yoga

Subscribe